Accumulating evidence indicates a link between gut barrier dysfunction and hypertension. However, it is unclear whether hypertension causes gut barrier dysfunction or vice versa, and whether the gut microbiome plays a role. To understand this relationship, first, we cross-sectionally examined 153 nonhuman primates(NHPs), mean age 16±0.4yr and 129(84.3%) were females for cardio-metabolic risk factors and gut barrier function. This analysis identified blood pressure and age as specific factors that independently associated with microbial translocation. We then longitudinally tracked male, age-matched spontaneously hypertensive NHPs to normotensives(n=16), mean age 5.8±0.5yr, to confirm hypertension-related gut barrier dysfunction and explore the role of microbiome by comparing groups at baseline, 12 and 27 months. Collectively, hypertensive animals in both studies showed evidence of gut barrier dysfunction(i.e.,microbial translocation), as indicated by higher plasma levels of lipopolysaccharide-binding protein (LBP)-1, when compared to normotensive animals. Further, plasma LBP-1 levels were correlated with diastolic blood pressure, independent of age and other health markers, suggesting specificity of the effect of hypertension on microbial translocation. In over 2 years of longitudinal assessment, hypertensive animals had escalating plasma levels of LBP-1 and greater bacterial gene expression in mesenteric lymph nodes compared to normotensive animals, confirming microbes translocated across the intestinal barrier. Concomitantly, we identified distinct shifts in the gut microbial signature of hypertensive versus normotensive animals at 12 and 27 months. These results suggest that hypertension contributes to microbial translocation in the gut and eventually unhealthy shifts in the gut microbiome, possibly contributing to poor health, providing impetus for the hypertension management.